Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
2004/08/01 by Bridget F. Grant, Frederick S. Stinson, Deborah A. Dawson +6 · 160 citations
Medicine · Neuroscience · Psychology · Social Sciences · #Alcoholism and Thiamine Deficiency #Anxiety #Anxiety disorder #Clinical psychology #Comorbidity #Environmental health #Medicine #Mental Health Research Topics #Mood #Mood disorders #National Comorbidity Survey #Neurotransmitter Receptor Influence on Behavior #Population #Prevalence of mental disorders #Psychiatry #Psychology #Substance Abuse Treatment and Outcomes #Substance abuse #Substance dependence #Youth Substance Use and School Attendance
paper · open access · doi:10.1001/archpsyc.61.8.807
published in PubMed 61(8), 807-16 (National Institutes of Health)
openalex publication_date 2004/08/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/23
Abstract
BACKGROUND: Uncertainties exist about the prevalence and comorbidity of substance use disorders and independent mood and anxiety disorders. OBJECTIVE: To present nationally representative data on the prevalence and comorbidity of DSM-IV alcohol and drug use disorders and independent mood and anxiety disorders (including only those that are not substance induced and that are not due to a general medical condition). DESIGN: Face-to-face survey. SETTING: The United States. PARTICIPANTS: Household and group quarters' residents. MAIN OUTCOME MEASURES: Prevalence and associations of substance use disorders and independent mood and anxiety disorders. RESULTS: The prevalences of 12-month DSM-IV independent mood and anxiety disorders in the US population were 9.21% (95% confidence interval [CI], 8.78%-9.64%) and 11.08% (95% CI, 10.43%-11.73%), respectively. The rate of substance use disorders was 9.35% (95% CI, 8.86%-9.84%). Only a few individuals with mood or anxiety disorders were classified as having only substance-induced disorders. Associations between most substance use disorders and independent mood and anxiety disorders were positive and significant (P<.05). CONCLUSIONS: Substance use disorders and mood and anxiety disorders that develop independently of intoxication and withdrawal are among the most prevalent psychiatric disorders in the United States. Associations between most substance use disorders and independent mood and anxiety disorders were overwhelmingly positive and significant, suggesting that treatment for a comorbid mood or anxiety disorder should not be withheld from individuals with substance use disorders.
Cited by
- Rumination as a transdiagnostic factor in depression and anxiety
- Depression Among Methamphetamine Users
- The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies.
- Is there a general factor of prevalent psychopathology during adulthood?
- Psychometric and Genetic Architecture of Substance Use Disorder and Behavioral Disinhibition Measures for Gene Association Studies
- Health Problems and Medical Utilization Associated With Gambling Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
- Depression and ADHD-Related Risk for Substance Use in Adolescence and Early Adulthood: Concurrent and Prospective Associations in the MTA
- How people decide to consume (more) alcohol when feeling stressed
- Prevalence and correlates of alcohol, cannabis, and tobacco use disorder in DSM-5 generalized anxiety disorder: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III
- A gender perspective of dual diagnosis: a narrative review
- Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder
- A longitudinal person‐centered analysis of anxiety sensitivity risk for young adult alcohol misuse: Examining the role of injunctive norms
- A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia
- Childhood emotional maltreatment and mental disorders: Results from a nationally representative adult sample from the United States
- Problematic alcohol and cannabis use among young adults: The roles of depression and discomfort and distress tolerance
- Lenin: An Impression
- The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders
- Exercise-based treatments for substance use disorders: evidence, theory, and practicality
- Management of Alcohol Abuse
- Recovery from DSM‐IV alcohol dependence: United States, 2001–2002
- Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States
- A Comparison of Factors Associated With Substance-Induced Versus Independent Depressions
- Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse
- Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis
- Three Approaches to Understanding and Classifying Mental Disorder: ICD-11, DSM-5 , and the National Institute of Mental Health’s Research Domain Criteria (RDoC)
- Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders
- Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. [europepmc]
- The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. [europepmc]
- Alcohol: effects on neurobehavioral functions and the brain. [europepmc]
- Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. [europepmc]
- Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. [europepmc]
- Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. [europepmc]
- Psychiatric disorders in pregnant and postpartum women in the United States. [europepmc]
- Sexual orientation, substance use behaviors and substance dependence in the United States. [europepmc]
- Dimensions of sexual orientation and the prevalence of mood and anxiety disorders in the United States. [europepmc]
- Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway. [europepmc]
- Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). [europepmc]
- Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. [europepmc]
- Rumination as a transdiagnostic factor in depression and anxiety. [europepmc]
- An internalizing pathway to alcohol use and disorder. [europepmc]
- Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. [europepmc]
- Is there a general factor of prevalent psychopathology during adulthood? [europepmc]
- DSM-5 criteria for substance use disorders: recommendations and rationale. [europepmc]
- Impacts of adverse childhood experiences on health, mental health, and substance use in early adulthood: a cohort study of an urban, minority sample in the U.S. [europepmc]
- Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. [europepmc]
- The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. [europepmc]
- Depression and postoperative complications: an overview. [europepmc]
- US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. [europepmc]
- Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. [europepmc]
- Psychiatric comorbidities in alcohol use disorder. [europepmc]
- Alcohol Use Disorder and Depressive Disorders. [europepmc]
Related